Skip to content

Towards Optimal Fertility, Fathering and Fatherhood studY

Investigating Male Factors and Their Relationships With Reproductive Health Outcomes in Singapore: Towards Optimal Fertility, Fathering and Fatherhood studY

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06293235
Acronym
TOFFFY
Enrollment
960
Registered
2024-03-05
Start date
2024-06-21
Completion date
2027-09-01
Last updated
2026-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility Issues, Reproductive Issues

Keywords

Male, Risk factor, Lifestyle, Semen analysis, Epigenetic, Oxidative stress, DNA fragmentation

Brief summary

This case-control study involving fertile and subfertile couples aims to identify male factors related to pregnancy likelihood, create a fertility index measure combining male and female factors to predict pregnancy likelihood, and examine how male factors relate to the semen physical and biological characteristics.

Detailed description

Paternal contributions to fertility and reproductive health outcomes have been understudied, despite promising evidence from animal studies. This study aims to investigate the male contribution to pregnancy likelihood and explore the underlying biological mechanisms. Specifically, the investigators aim to (1) identify male factors associated with pregnancy rate; (2) develop a fertility index combining modifiable factors for both males and females to predict pregnancy rate; and (3) explore the relationship of male modifiable factors with semen physical and molecular characteristics. This is a case-control study with 480 fertile and subfertile males (along with their female partners), recruited from KK Women's and Children's Hospital. The investigators will use questionnaires to collect data on socio-demographic characteristics, clinical, lifestyle, and environmental factors; analyze metabolic and stress biomarkers from blood samples; and measure semen parameters including sperm motility, density, morphology, volume, DNA fragmentation, DNA methylation, gene expression, and seminal plasma oxidative status. Findings from this proposed study will pave the way for developing lifestyle-based or medical interventions to enhance male and couple reproductive health, and potentially benefiting future offspring health.

Interventions

OTHERLifestyle and metabolic indicators

Socio-demographics, health history, behavioural characteristics, environmental exposures, anthropometric measurements, body fat composition, metabolic and stress biomarkers, semen physical and molecular characteristics.

Sponsors

KK Women's and Children's Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
21 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

Subfertile couples: * men aged ≥21-49 years * men with a female partner aged 21-39 years * couples who are not able to conceive for at least 12 months * couples who are Singapore citizen or permanent resident Fertile couples: * men aged 21-49 years * men with a female partner aged 21-39 years * men with proven fertility defined as those female partners who are currently pregnant and with viable intrauterine pregnancy at gestational weeks of less or equal to 16 at the time of the study * couples with attempted time to conceive within 12 months to achieve this pregnancy or with unplanned pregnancy * couples who are Singapore citizen or permanent resident

Exclusion criteria

Subfertile couples: * male infertility of a known aetiology including azoospermia, retrograde ejaculation, genetic disorders, cancer treatment, or testes trauma * female infertility diagnosis as confirmed by diagnostic imaging or having severe endometriosis * female partners with irregular menstrual cycle \>35 days * couples with known chromosomal abnormalities Fertile couples: * couples who achieve pregnancy after oocyte or spermatozoa donation * couples with known chromosomal abnormalities * female partners with known uterine abnormalities

Design outcomes

Primary

MeasureTime frameDescription
Pregnancy rateUp to 16 weeks of gestationDefined by viable intrauterine pregnancy at gestational weeks of less or equal to 16 at the time of the study

Secondary

MeasureTime frameDescription
Fertility indexThrough study completion, an average of 3 yearsDefined by a composite index score derived from both male and female predictive factors
Oxidative stressThrough study completion, an average of 3 yearsDefined by oxidative status measured from blood and semen samples using the micro-NMR
Semen volumeUp to 2 yearsAssessed by semen analysis in ml
Sperm concentrationUp to 2 yearsAssessed by semen analysis in million/ml
Sperm total motilityUp to 2 yearsAssessed by semen analysis in percent
Sperm progressive motilityUp to 2 yearsAssessed by semen analysis in percent
Total progressive motile sperm countUp to 2 yearsmeasured by multiplying the semen volume (ml) by sperm concentration (million/ml) and the percentage of progressively motile sperm
Single strand sperm DNA fragmentationUp to 2 yearsMeasured by the AI-powered semen analyzer
Double strand sperm DNA fragmentationUp to 2 yearsMeasured by the AI-powered semen analyzer
mRNA levelThrough study completion, an average of 3 yearsFrom blood and semen samples through transcriptomics analysis
sncRNA levelThrough study completion, an average of 3 yearsFrom blood and semen samples through transcriptomics analysis
DNA methylationThrough study completion, an average of 3 yearsFrom blood and semen samples through bisulfite sequencing

Countries

Singapore

Contacts

CONTACTBenjarat Oh
benjarat.oh@kkh.com.sg63948105
PRINCIPAL_INVESTIGATORSee Ling Loy, PhD

KK Women's and Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026